Grifols (GIKLY) Cash & Equivalents (2010 - 2025)

Grifols (GIKLY) reported Cash & Equivalents of $923.1 million for Q4 2025, down 11.85% on a YoY basis from $1.0 billion in Q4 2024, and down 11.85% quarter-over-quarter from $1.0 billion in Q4 2024.

Grifols (GIKLY) Cash & Equivalents (2010 - 2025) Analysis & Trends

Grifols has reported Cash & Equivalents for 16 years, with the latest figure at $923.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 11.85% year-over-year to $923.1 million; the trailing twelve-month figure through Dec 2025 stood at $923.1 million (down 11.85% YoY), and the FY2025 full-year result was $923.1 million, down 11.85% from the prior year.
  • Cash & Equivalents for Q4 2025 stood at $923.1 million, down from $1.0 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $3.1 billion in Q4 2021, with the low at $560.1 million in Q4 2022.
  • Historically, Cash & Equivalents has averaged $1.2 billion across 5 years, with a median of $923.1 million in 2025.
  • Annual changes were most pronounced in 2021 — Cash & Equivalents soared 342.97% — and 2022, when it plunged 81.7%.
  • Grifols' Cash & Equivalents stood at $3.1 billion in 2021, then sank by 81.7% to $560.1 million in 2022, then grew by 1.62% to $569.2 million in 2023, then soared by 83.99% to $1.0 billion in 2024, then retreated by 11.85% to $923.1 million in 2025.
  • The last three Cash & Equivalents figures came in at $923.1 million (Q4 2025), $1.0 billion (Q4 2024), and $569.2 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 4.64 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 5.28 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 21.69 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 9.39 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 5.33 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 12.04 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 7.63 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 1.70 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 9.57 Bn
10 Grifols - - - 923.09 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 923.09 Mn
Dec 31, 2024 1.05 Bn
Dec 31, 2023 569.17 Mn
Dec 31, 2022 560.12 Mn
Dec 31, 2021 3.06 Bn
Dec 31, 2020 691.11 Mn
Sep 30, 2020 1.21 Bn
Mar 31, 2020 -130.24 Mn
Dec 31, 2019 1.14 Bn
Sep 30, 2019 881.43 Mn
Mar 31, 2019 -541.80 Mn
Dec 31, 2018 1.18 Bn
Sep 30, 2018 676.95 Mn
Jun 30, 2018 797.82 Mn
Mar 31, 2018 21.42 Mn
Dec 31, 2017 1.04 Bn
Jun 30, 2017 824.90 Mn
Mar 31, 2017 156.72 Mn
Dec 31, 2016 966.36 Mn
Sep 30, 2016 1.01 Bn